About Us

Anaxiom is a privately held medical device company focused on redefining the treatment of obesity through innovative, minimally invasive solutions.  Our mission is to provide patients and physicians with a safer, more effective alternative to traditional surgical and pharmacologic approaches.
 
Obesity is one of the most important public health problems in the world today, impacting more than one billion people worldwide and more than 109 million adults in the United States alone.  It is a chronic and complex disease that, if left untreated, can lead to serious health consequences and significantly increase the risk of premature death.  
 
Anaxiom has developed a novel implantable device to modulate blood flow leading to controlled weight loss utilizing a conventional percutaneous approach.  Anaxiom is committed to providing innovative solutions to help people struggling with obesity.